(Q38474433)

3 September 2017

title

Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation (English)

1 reference

3 September 2017

main subject

hepatocellular carcinoma

1 reference

Shin Hwang

1

1 reference

3 September 2017

Chul-Soo Ahn

2

1 reference

3 September 2017

Ki-Hun Kim

3

1 reference

3 September 2017

Deok-Bog Moon

4

1 reference

3 September 2017

Tae-Yong Ha

5

1 reference

3 September 2017

Gi-Won Song

6

1 reference

3 September 2017

Dong-Hwan Jung

7

1 reference

3 September 2017

Gil-Chun Park

8

1 reference

3 September 2017

Young-Dong Yu

9

1 reference

3 September 2017

Pyoung-Jae Park

10

1 reference

3 September 2017

Young-Il Choi

11

1 reference

3 September 2017

Kyoung-Won Kim

12

1 reference

3 September 2017

Young-Suk Lim

13

1 reference

3 September 2017

Han Chu Lee

14

1 reference

3 September 2017

Eun-Sil Yu

15

1 reference

3 September 2017

Sung-Gyu Lee

16

1 reference

3 September 2017

publication date

29 March 2011

1 reference

Journal of Gastrointestinal Surgery

3 September 2017

published in

1 reference

3 September 2017

volume

15

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

971-981

1 reference

Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Toward 300 liver transplants a year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

[Practice guidelines for management of hepatocellular carcinoma 2009].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liberal selection criteria for liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on mila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Treatment before liver transplantation for HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1467-0

A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation

1 reference

12 December 2020

The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma

1 reference

12 December 2020

Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation

1 reference

12 December 2020

Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series

1 reference

12 December 2020

Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment

1 reference

12 December 2020

Living-donor liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition?

1 reference

12 December 2020

Histopathologic characteristics of incidental hepatocellular carcinoma after liver transplantation

1 reference

12 December 2020

10.1007/S11605-011-1467-0

Identifiers

DOI

1 reference

3 September 2017

1 reference